Presentation
Targeting Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo
Gorsuch, Cassandra L., et al. European Society of Gene & Cell Therapy 2022.
AAV-Meganuclease-mediated Gene Targeting Achieves Efficient and Sustained Transduction in Newborn and Infant Macaque Liver
Wang L., et al. American Society of Gene and Cell Therapy 2022 Annual Meeting.
Targeting the Hepatitis BcccDNA with a Sequence-specific ARCUS Nuclease to Eliminate Hepatitis B Virus
Gorsuch C., et al. American Society of Gene and Cell Therapy 2022 Annual Meeting.
Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion is Highly Active in Subjects with Relapsed/Refractory B-Cell Malignancies
Shah, B.D. et al. Blood. 138, 302 (2021). ASH 2021 Annual Meeting.
Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic ‘Off-the-Shelf’ CD19-Directed CAR-T for Patients with Relapsed/Refractory (R/R) CD19+ B-ALL
Nitin, J. et al. Blood. 138, 650 (2021). ASH 2021 Annual Meeting.